Complete BCDA Stock Valuation Analysis
Comprehensive intrinsic value analysis using 1 different methodologies
BCDA Peer Valuation Analysis
Relative valuation based on comparable company trading multiples
Peer Valuation Analysis
Fair Value Range Analysis
Based on median multiples from 7 peer companies in Healthcare
P/E Ratio
$-17.81
-891.5%
Peer Median: 9.8x
EV/EBITDA
$0.00
-100.0%
Peer Median: 0.0x
P/S Ratio
$0.11
-95.3%
Peer Median: 3.1x
Interpretation: Each multiple provides a different perspective on fair value. Consider which multiple is most relevant for BCDA's business model and current situation.
Multiple Comparison
| Multiple | BCDA Current | Peer Median | Peer Average | Premium/Discount | Assessment |
|---|---|---|---|---|---|
| P/E Ratio | -1.2x | 9.8x | 9.8x | -112.6% | Undervalued |
| EV/EBITDA | Infinityx | 0.0x | 0.0x | Infinity% | Overvalued |
| P/S Ratio | 65.1x | 3.1x | 5.2x | 2029.6% | Overvalued |
Peer Companies
Click any company to view their valuation
| Company | Market Cap | P/E Ratio | EV/EBITDA | P/S Ratio |
|---|---|---|---|---|
| $0.01B | 0.0x | 0.0x | 3.1x | |
| $0.30B | 0.0x | 0.0x | 0.0x | |
| $0.01B | 0.0x | 0.0x | 0.0x | |
| $0.01B | 0.0x | 0.0x | 59.9x | |
| $0.01B | 9.8x | -1.4x | 309.8x | |
| $0.01B | 0.0x | 0.0x | 0.2x | |
| $0.01B | 0.0x | 0.0x | 12.4x |